LOVELAND, OH — Sirrus Inc., a developer of electron-deficient monomers and oligomers, has completed construction of a $2 million bench plant expansion to increase production of methylene malonate monomers and oligomers.
The expanded bench facility represents an important step in the design and construction of Sirrus’ full-scale production facility, which is scheduled to break ground in 2019. “The expanded facility makes use of equipment that is scalable. This affords our engineering partners access to continuous process data, testing of control strategies and demonstration of in-process stabilization. This combination provides extreme confidence in producing these monomers in commercial quantities at our desired product specifications,” said Jeff Uhrig, Sirrus CEO.
The pilot facility also gives Sirrus and its development partners access to larger quantities of the company’s methylene malonate monomers. This will allow partners to conduct line trials and customer qualification, an important step towards advancing commercial off-take discussions. When operating continuously, the expanded facility will be able to produce up to two tonnes per month of monomer.
Sirrus’ core monomer and macromer products — Chemilian™ and Forza™ — have near-term applications in adhesives, sealants and coatings.